Published in Cell Mol Neurobiol on August 01, 2006
Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology. J Inherit Metab Dis (2007) 1.41
Fetal inflammatory response and brain injury in the preterm newborn. J Child Neurol (2009) 1.36
Role of Lipids in Brain Injury and Diseases. Future Lipidol (2007) 1.23
Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res (2008) 1.14
Mass-spectrometry based oxidative lipidomics and lipid imaging: applications in traumatic brain injury. J Neurochem (2010) 1.14
Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia. Am J Obstet Gynecol (2009) 1.06
Dietary n-6 PUFA deprivation for 15 weeks reduces arachidonic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats. Biochim Biophys Acta (2008) 0.99
Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Neurobiol Aging (2014) 0.93
Activation and reversal of lipotoxicity in PC12 and rat cortical cells following exposure to palmitic acid. J Neurosci Res (2009) 0.91
Metabolite profiles correlate closely with neurobehavioral function in experimental spinal cord injury in rats. PLoS One (2012) 0.91
Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats. J Neurotrauma (2011) 0.90
DHA inhibits ER Ca2+ release and ER stress in astrocytes following in vitro ischemia. J Neurochem (2012) 0.86
SPARC overexpression inhibits cell proliferation in neuroblastoma and is partly mediated by tumor suppressor protein PTEN and AKT. PLoS One (2012) 0.86
Modulating the inflammatory properties of activated microglia with Docosahexaenoic acid and Aspirin. Lipids Health Dis (2013) 0.86
ER stress and effects of DHA as an ER stress inhibitor. Transl Stroke Res (2013) 0.85
Docosahexaenoic acid confers neuroprotection in a rat model of perinatal hypoxia-ischemia potentiated by Escherichia coli lipopolysaccharide-induced systemic inflammation. Am J Obstet Gynecol (2010) 0.84
Docosahexaenoic acid improves behavior and attenuates blood-brain barrier injury induced by focal cerebral ischemia in rats. Exp Transl Stroke Med (2015) 0.83
Chronic Repetitive Mild Traumatic Brain Injury Results in Reduced Cerebral Blood Flow, Axonal Injury, Gliosis, and Increased T-Tau and Tau Oligomers. J Neuropathol Exp Neurol (2016) 0.82
Cognition, dopamine and bioactive lipids in schizophrenia. Front Biosci (Schol Ed) (2011) 0.81
DHA but Not EPA Emulsions Preserve Neurological and Mitochondrial Function after Brain Hypoxia-Ischemia in Neonatal Mice. PLoS One (2016) 0.76
Fatty acid status and its relationship to cognitive decline and homocysteine levels in the elderly. Nutrients (2014) 0.76
Differential effect of maternal diet supplementation with alpha-Linolenic adcid or n-3 long-chain polyunsaturated fatty acids on glial cell phosphatidylethanolamine and phosphatidylserine fatty acid profile in neonate rat brains. Nutr Metab (Lond) (2010) 0.75
Imaging mass spectrometry reveals loss of polyunsaturated cardiolipins in the cortical contusion, hippocampus, and thalamus after traumatic brain injury. J Neurochem (2016) 0.75
Dysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonism. Sci Rep (2016) 0.75
Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci (2004) 9.29
Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci (2003) 6.53
Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem (2003) 4.58
The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci (1990) 4.34
Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A (2004) 4.28
Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med (1991) 3.99
Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem (2003) 3.80
Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab (1999) 3.48
Ischemic tolerance and endogenous neuroprotection. Trends Neurosci (2003) 3.44
Fish consumption and major depression. Lancet (1998) 3.42
The base excision repair pathway. Trends Biochem Sci (1995) 3.24
Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr (2000) 2.92
Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med (1999) 2.84
Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol (2003) 2.57
Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol (2004) 2.45
A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev (1992) 2.32
Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene (2001) 2.17
A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol Vis (2001) 2.09
Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab (2004) 2.02
Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res (2003) 1.92
Caspase-activation pathways in apoptosis and immunity. Immunol Rev (2003) 1.87
A2E-epoxides damage DNA in retinal pigment epithelial cells. Vitamin E and other antioxidants inhibit A2E-epoxide formation. J Biol Chem (2003) 1.83
Oxygen free radicals and brain dysfunction. Int J Neurosci (1991) 1.79
Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem (1998) 1.71
Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res (2004) 1.69
Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res (2003) 1.69
Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci (1999) 1.67
Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. Proc Natl Acad Sci U S A (2001) 1.67
Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation (1999) 1.65
Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection. Stroke (2004) 1.47
Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis Lecture. Stroke (2003) 1.45
Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr (2002) 1.44
Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx (2004) 1.44
Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated CA2+ and Na+: implications for neurodegeneration. J Neurochem (1994) 1.38
Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J Biol Chem (2000) 1.38
The cardiovascular protective role of docosahexaenoic acid. Eur J Pharmacol (1996) 1.36
Visual membranes: specificity of fatty acid precursors for the electrical response to illumination. Science (1975) 1.31
Retinal light damage in rats with altered levels of rod outer segment docosahexaenoate. Invest Ophthalmol Vis Sci (1996) 1.26
Low docosahexaenoic acid levels in rod outer segments of rats with P23H and S334ter rhodopsin mutations. Mol Vis (2002) 1.23
Targeting the host inflammatory response in traumatic spinal cord injury. Curr Opin Neurol (2002) 1.19
The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: visual transduction. J Mol Neurosci (2001) 1.15
Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung. Br J Cancer (1997) 1.14
Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat (2002) 1.11
Neuroinflammation, COX-2, and ALS--a dual role? Exp Neurol (2004) 1.10
Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci (1998) 1.09
Endogenous fatty acids are covalently and noncovalently bound to interphotoreceptor retinoid-binding protein in the monkey retina. J Biol Chem (1985) 1.08
Alterations in retinal rod outer segment fatty acids and light-damage susceptibility in P23H rats. Mol Vis (2002) 1.03
Recycling of docosahexaenoic acid in rat retinas during n-3 fatty acid deficiency. J Lipid Res (1991) 1.00
Docosahexaenoic acid modulates the interactions of the interphotoreceptor retinoid-binding protein with 11-cis-retinal. J Biol Chem (1996) 0.99
Protein extravasation and cellular uptake after high-dose human-albumin treatment of transient focal cerebral ischemia in rats. Brain Res (1999) 0.98
Mammalian phospholipases A(2): mediators of inflammation, proliferation and apoptosis. Prog Lipid Res (2001) 0.98
Ca(2+)-induced mitochondrial membrane permeabilization: role of coenzyme Q redox state. Am J Physiol (1995) 0.97
Retinal pigment epithelial cells play a central role in the conservation of docosahexaenoic acid by photoreceptor cells after shedding and phagocytosis. Curr Eye Res (1992) 0.95
Functional coupling between secretory and cytosolic phospholipase A2 modulates tumor necrosis factor-alpha- and interleukin-1beta-induced NF-kappa B activation. J Biol Chem (2001) 0.95
Low docosahexaenoic acid levels in rod outer segment membranes of mice with rds/peripherin and P216L peripherin mutations. Invest Ophthalmol Vis Sci (2001) 0.95
Bcl-Xshort is elevated following severe global ischemia in rat brains. Brain Res (1997) 0.92
Both FGF1 and bcl-x synthesis are necessary for the reduction of apoptosis in retinal pigmented epithelial cells by FGF2: role of the extracellular signal-regulated kinase 2. Oncogene (1999) 0.91
Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brain. Neurochem Res (2001) 0.89
Apoptotic and anti-apoptotic synaptic signaling mechanisms. Brain Pathol (2000) 0.89
Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome. Atherosclerosis (2003) 0.89
Dietary eicosapentaenoic acid and docosahexaenoic acid from fish oil. Their incorporation into advanced human atherosclerotic plaques. Arterioscler Thromb (1991) 0.88
Acyl groups, molecular species, and labeling by 14C-glycerol and 3H-arachidonic acid of vertebrate retina glycerolipids. Adv Exp Med Biol (1977) 0.80
Omega-3 lipid infusion in a heart allotransplant model. Shift in fatty acid and lipid mediator profiles and prolongation of transplant survival. Circulation (1996) 0.79
Fish oil and inflammatory disease: is asthma the next target for n-3 fatty acid supplements? Nutr Rev (2004) 0.79
[Results of GISSI Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSI Prevenzione]. Cardiologia (1999) 0.75